Special Concerns Relating To Promotional Labeling And Advertising For Medical Devices.

Slides:



Advertisements
Similar presentations
Direct-to-Consumer Advertising of Genetic Tests
Advertisements

An Overview of Direct-to-Consumer Prescription Drug Promotion Nancy M. Ostrove, Ph.D. Risk Communication Advisory Committee May 15, 2008.
Mobile Payments and the FTC Manas Mohapatra Director of Mobile Policy Mobile Technology Unit Federal Trade Commission The views expressed are not necessarily.
Australian Guidance Document Number xx Cathy Thomas Professional Representation OT Australia WA.
What Are Your Products Doing Online? Presented by Anthony V. Lupo Sarah E. Bruno Arent Fox LLP Washington, DC | New York, NY | Los Angeles, CA August 20,
Advertising and Sales Promotion ©2013 Cengage Learning. All Rights Reserved. Chapter 13.
Enforcement in the Pharmaceutical Industry Michael K. Loucks First Assistant U.S. Attorney United States Attorney’s Office District of Massachusetts October.
Becker Grand Rounds: Wally Pellerite June 30, 2011.
Chapter Three Marketing Ethics, Regulations, and Social Responsibility.
Click the mouse button or press the space bar to display information. How many people know a lot about their family health history? Why is this important?
Ministry of Industry, Trade & Labor Head of Section in Charge of Foreign Workers Rights at Work The Role of a Governmental Ombudsman In Charge of Foreign.
Outline Advertising and society Ethical issues in advertising
FSA Enforcement Ian Mason Head of Department, Wholesale Group Enforcement Division June 2005.
Complying With The Federal Information Security Act (FISMA)
Vendor Risk: Effective Management is Essential
The Commercial Speech Doctrine Truthful and non-misleading advertising about lawful goods and services receives an intermediate level of First Amendment.
1 Speech that FDA Regulates William A. McConagha Office of Accountability Food & Drug Administration Risk Communication Advisory Committee February 28,
Regulation of Drug Marketing Introduction to Drug Law and Regulation FDLI Workshop April 28-29, 2003 Teaneck, New Jersey Philip Katz Crowell & Moring LLP.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
© 2010 Dorsey & Whitney LLP Social Media Friday, September 17, 2010 The Committee on Finance & Information Technology (CFIT)
The U.S. Approach to Consumer Protection in the Online World U.S. Presentation FTAA Joint Government Private Sector Committee on Electronic Commerce 13th.
Objective Understand Sales and Consumer Laws BB30 Business Law 6.01 Summer 2013.
Council for Responsible Nutrition HOT TOPICS IN SOCIAL MEDIA HOT TOPICS IN SOCIAL MEDIA July 9, 2014 Rend Al-Mondhiry Regulatory Counsel Council for Responsible.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
CASTRO VALLEY ADULT AND CAREER EDUCATION CMA PROGRAM FOOD AND DRUG ADMINISTRATION.
Top 10 Medical Device Citations
Online Medication Farrokh Alemi, PhD Based on Grahame-Smith, D. G. CBE lecture.
1 SECTION 337 INVESTIGATIONS Managing Intellectual Property IP In China April 30, 2013 New York, New York.
Chapter 6 CRISIS MANAGEMENT. Introduction - Crisis: ◦is a situation that specifically involves a pharmaceutical product, medical device or activity with.
Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United.
CONTEMPORARY ECONOMICS© Thomson South-Western 20.3Consumer Protection  Explain why consumers need the government to protect them from defective or dangerous.
“513(g)s” Requests for Information Lawrence “Jake” Romanell, RM (AAM) Office of Device Evaluation Center for Devices and Radiological Health.
Chapter 45 Consumer Law McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
Communicating and Marketing Your Product or Technology in Today’s Healthcare Environment Resources Joni Bradley,
What Are Your Products Doing Online? Presented by Sarah E. Bruno Arent Fox LLP Washington, DC | New York, NY | Los Angeles, CA August 19, 2008.
FDLI Introduction to Medical Device Law and Regulation Other Postmarket Controls Philip Katz (202) October 29, 2002 Washington,
Federal Agencies and Laws for Consumer Rights
Federal Trade Commission FTC & Spam. Federal Trade Commission CAN-SPAM Act of 2003 (“Controlling the Assault of Non-Solicited Pornography.
Regulatory Factors Affecting Advertising
FDA Regulation of Tobacco Washington, DC October 21, 2015 Substantial Equivalence – Where do we Stand? Stacy Ehrlich, Partner, Kleinfeld Kaplan & Becker.
Enforcement What to Expect From the Water Boards, and What to Look for Locally ENTS Workshop August Mark Bradley Office of Enforcement CA State.
Enforcement Litigation and Compliance Washington, DC December 9- 10, 2015 Food: Industry Self Regulation Hal Hodes, Attorney, National Advertising Division.
Copyright © 2015 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 3 Privacy, Confidentiality, and Security.
Mission, Organization, and Operations Presentation by Gray Etheredge and Cathy Chang January 20, 2004.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
©2007 Fredrikson & Byron P.A. Presented by
Chapter 6 legal and ethical issues Section 6.1 Government and Laws
Suzanne Sechen, Ph.D. Leader, Ruminant Drugs Team Division of Production Drugs Office of New Animal Drug Evaluation, CVM Labeling Issues.
Public Communications Law Lecture 9 Slide 1 Commercial Speech and the First Amendment Commercial speech (advertising products, etc.) does enjoy certain.
November 19, Stacy Ehrlich, Esq. Partner Kleinfeld Kaplan & Becker LLP Washington, DC
Promotion of Prescription Drugs and Biologics Thomas O. Henteleff Kleinfeld, Kaplan and Becker LLP Company logo here.
FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.
FDA Draft Guidance Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved.
Marketing Principles CHAPTER 6 SECTION 1.  Government actions have a great impact on business and its operations.  The US Government has three branches:
 The U.S. Securities and Exchange Commission (SEC) oversees the key participants in the securities world.  Concerned with promoting disclosure of important.
0 Case Study 1 Advertising. ACADEMY OF OPHTHALMOLOGY Disclosure  The speaker has no financial interest in the subject matter of this.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Washington Legal Foundation Advocate for Freedom and Justice ® WLF Balancing the Public's Right to Know With the Government's Obligation to Protect Patients.
Prescription Drug Advertising
Ch. 26 Becoming a Smart Consumer
Federal Agencies and Laws for Consumer Rights
Responding to a Data Breach 360° of IT Compliance
ALL ABOUT THE FTC By: Brandon Baldwin.
Advertising and Social Responsibility
Current Privacy Issues That May Affect Your Credit Union
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
Risk Management: why and how to protect your health center
Making Your IRBs and Clinical Investigators HIPAA-Ready
Move this to online module slides 11-56
Compliance in the New Environment
Presentation transcript:

Special Concerns Relating To Promotional Labeling And Advertising For Medical Devices

Thomas O. Henteleff Stacy L. Ehrlich Kleinfeld, Kaplan and Becker, LLP May 3, 2005

Level Playing Field Issues Inherent Problems of Maintaining Different Regulatory Standards Different Regulatory Standards FDA vs. FTC FDA vs. FTC Drugs vs. Devices Drugs vs. Devices FDA Staff with Different Educational Backgrounds and Training FDA Staff with Different Educational Backgrounds and Training

Level Playing Field Issues Inherent Problems of Maintaining (Cont.) Inherent Problems of Maintaining (Cont.) FDA Staff with Different Workload FDA Staff with Different Workload Limited Financial and Manpower Resources Limited Financial and Manpower Resources Lack of Appreciation of Relevant Facts Due to Confidentiality and Open Investigation File Considerations Lack of Appreciation of Relevant Facts Due to Confidentiality and Open Investigation File Considerations

Level Playing Field Issues Procedures to Address Procedures to Address Internal Guidance Documents Internal Guidance Documents Industry Guidance Documents Industry Guidance Documents FDA Staff Training Programs FDA Staff Training Programs FDA Evaluation and Monitoring Procedures FDA Evaluation and Monitoring Procedures

Level Playing Field Issues Procedures to Address (Cont.) Administrative Procedures Administrative Procedures Request for Internal Agency Review Request for Internal Agency Review CDRH Ombudsman CDRH Ombudsman Office of Chief Mediator and Ombudsman Office of Chief Mediator and Ombudsman Citizens’ Petitions Citizens’ Petitions Petitions for Reconsideration Petitions for Reconsideration

Level Playing Field Issues Procedures to Address (Cont.) Procedures to Address (Cont.) Other Procedures Other Procedures Cease and Desist Letters Trade Complaints Filed With Government NAD Complaint Lanham Act Litigation

Level Playing Field Issues Procedures to Address (Continued) Procedures to Address (Continued) Other Procedures (Continued) Other Procedures (Continued) Litigation to Enforce Agency Action to Treat Similar Situations in a Similar Manner Allergan v. Shalala Allergan v. Shalala Bracco Diagnostics v. Shalala Bracco Diagnostics v. Shalala U.S. v. An Article of Device... Diapulse U.S. v. An Article of Device... Diapulse

Internet Issues Scope Scope Advantages Advantages Privacy Privacy Convenience Convenience Potential Cost Savings Potential Cost Savings

Internet Issues Risks Risks Broad Coverage/Low-Cost Broad Coverage/Low-Cost Health Risks Health Risks Economic Risks Economic Risks

Internet Issues Jurisdiction Jurisdiction Labeling or Advertising Labeling or Advertising Restricted vs. Rx and OTC Devices FDA vs. FTC Does It Make A Difference? Does It Make A Difference? Joint Prohibition Against False and Misleading Representations Adequate Substantiation Clearance Limitations Remedies

Internet Issues Legitimate Prescriptions Legitimate Prescriptions Online Questionnaires Online Questionnaires Current Prescriptions Current Prescriptions Legitimate Source Legitimate Source Fairness to Contact Lens Consumer Act Fairness to Contact Lens Consumer Act

Internet Issues Self-Policing Self-Policing Certification Certification Monitoring Monitoring Consumer Education Consumer Education Enforcement Enforcement Operation Cure-All Operation Cure-All Cyber Warning Letters Cyber Warning Letters

Internet Issues Electronic Labeling Electronic Labeling Advantages Advantages Section 206 MDUFMA Section 206 MDUFMA Provisions Provisions Scope Scope

Market Integrity Issues Unapproved Products/Uses Unapproved Products/Uses False or Misleading Claims False or Misleading Claims Counterfeit Counterfeit Importation Importation Black Market Black Market Gray Market Gray Market Kickback Kickback

Questions? Stacy Ehrlich Kleinfeld, Kaplan and Becker (202)